Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Ductal Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07627711
What this trial is testing

Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally AdvancedMetastatic Disease
Beijing Biotech 42
Testing effectiveness (Phase 2)WithdrawnNCT03374852
What this trial is testing

CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Not applicableLooking for participantsNCT07340151
What this trial is testing

Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Adenocarcinoma of the Pancreas
The University of Texas Health Science Center at San Antonio 40
Not applicableLooking for participantsNCT05752812
What this trial is testing

The HELPP Score: A Pretreatment Score to Predict Survival in Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Medical University of Vienna 1,500
Testing effectiveness (Phase 2)WithdrawnNCT00226746
What this trial is testing

Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer

Who this might be right for
Carcinoma, Pancreatic Ductal
New York Presbyterian Brooklyn Methodist Hospital
Large-scale testing (Phase 3)Looking for participantsNCT06989437
What this trial is testing

Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Who this might be right for
CachexiaMetastatic Pancreatic Ductal Adenocarcinoma
Pfizer 982
Not applicableLooking for participantsNCT04571294
What this trial is testing

Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy

Who this might be right for
Pancreas CancerPancreaticoduodenal LymphadenopathyPancreas Adenocarcinoma
Humanitas Hospital, Italy 180
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07685470
What this trial is testing

MRG003 With Gemcitabine for Second-line Advanced PDAC

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Second Line Treatment
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)UnknownNCT02926183
What this trial is testing

Study of NAC of GA Therapy for Patients With BRPC

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Wakayama Medical University 60
Testing effectiveness (Phase 2)Looking for participantsNCT07483554
What this trial is testing

IBI343 in Combination Therapy for Advanced Malignant Solid Tumors

Who this might be right for
CLDN18.2 PositiveGastric/Gastroesophageal Junction AdenocarcinomaPancreatic Ductal Adenocarcinoma
Innovent Biologics (Suzhou) Co. Ltd. 389
Early research (Phase 1)Ended earlyNCT04809766
What this trial is testing

Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal AdenocarcinomaStage IV Pancreatic Cancer AJCC v8
Fred Hutchinson Cancer Center 9
Testing effectiveness (Phase 2)Ended earlyNCT06069778
What this trial is testing

Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
BioNTech SE 1
Not applicableUnknownNCT06119776
What this trial is testing

Most Total Pancreatectomies for Ductal Adenocarcinoma Can Be Replaced by Whipple Over the Splenic Artery: A Before and After Study

Who this might be right for
Ductal Adenocarcinoma of the Pancreas
National Taiwan University Hospital 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT04083599
What this trial is testing

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

Who this might be right for
Malignant Solid TumorNon-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+3 more
Genmab 350
Testing effectiveness (Phase 2)Ended earlyNCT03610490
What this trial is testing

Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma

Who this might be right for
Malignant Solid NeoplasmMetastatic Colorectal AdenocarcinomaMetastatic Ovarian Carcinoma+9 more
M.D. Anderson Cancer Center 16
Very early researchActive Not RecruitingNCT05336266
What this trial is testing

A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreas CancerPancreatic Ductal AdenocarcinomaPancreatic Cancer
Andrew Hendifar, MD 28
Testing effectiveness (Phase 2)UnknownNCT05048524
What this trial is testing

Peri-operative SLOG for Localized Pancreatic Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreas Cancer
National Health Research Institutes, Taiwan 64
Not applicableLooking for participantsNCT07324096
What this trial is testing

A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Mayo Clinic 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05968326
What this trial is testing

The Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC

Who this might be right for
Adenocarcinoma, Pancreatic Ductal
Genentech, Inc. 260
Not applicableLooking for participantsNCT05526443
What this trial is testing

Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic CancerAdvanced Pancreatic Carcinoma
Medical University of Graz 1,500
Next Page